MedCap (MCAP.ST) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

MCAP.ST · Stock Price

SEK 509.00+61.50 (+13.74%)

Market Cap: $825.3M

Historical price data

Market Cap: $825.3MFounded: 2005HQ: Stockholm, Sweden

Sector Ranking#33 in Digital Health & Biotech SaaS

Overview

MedCap is a Stockholm-listed investment holding company (MCAP.ST) with a mission to create sustainable value in life sciences by acting as a hands-on, long-term owner of innovative Nordic companies. Founded in 2005 and now valued at over $7 billion, it employs a diversified portfolio strategy across biotech and medtech, leveraging operational expertise to accelerate portfolio companies' growth. Its success is driven by capital appreciation, strategic exits, and dividends from a mature portfolio, positioning it as a unique and influential platform in the regional ecosystem.

Biotech

Technology Platform

MedCap's platform is its integrated investment and active ownership engine, providing portfolio companies with strategic governance, operational support, business development, and network access to accelerate growth.

Funding History

1

IPOUndisclosedUndisclosedJun 15, 2001

Opportunities

Capitalizing on the 'funding gap' for scaling innovative Nordic life science companies, exposure to high-growth sectors like specialty pharma and digital medtech, and favorable exit environment via industry consolidation.

Risk Factors

Concentration risk in portfolio holdings, inherent sector risks of clinical/regulatory failure, execution risk of the active ownership model, and liquidity risk associated with valuing and exiting private investments.

Competitive Landscape

Competes with traditional VC (differentiates via permanent capital), pharma corporate VC (differentiates via independent financial focus), and PE firms (differentiates via earlier-stage, sector-pure focus). Key advantages are its public listing, deep regional expertise, and hands-on value-add model.